glp-1 agonists vs bariatric surgery weight loss comparison vs. Medication: What's Better? Ozempic or Bariatric Surgery: Which

Imbalance towards the GIP receptor, combined with distinct signaling properties at the GLP-1 receptor, together may account for the promising efficacy of tirzepatide as observed in various cell models, isolated islets, and perfused pancreas (86)

Epidemiological and genetic data are supportive

Controlling glucose levels: In the pancreas, the proglucagon can convert into glucagon, which in turn signals the liver to release glucose

The FDA Adverse Event Reporting System shows a likely link between GLP-1 RAs (specifically liraglutide) and increased risk of pancreatitis

The trend warrants further investigation, as even modest reductions in hospitalization could have important clinical and economic implications if confirmed in larger datasets

Both of these options offer potential solutions to help reduce your overall body weight, but are very different in terms of outcomes, cost, and risks